LIPIGON PHARMACEUTICALS AB revenue for the last year amounted to 17.20 M SEK, the most of which — 16.41 M SEK — came from its highest performing source at the moment, Lipid-related Drugs, the year earlier bringing 2.21 M SEK. The greatest contribution to the revenue figure was made by Sweden — last year it brought LIPIGON PHARMACEUTICALS AB 16.41 M SEK, and the year before that — 2.21 M SEK.